The CLARITY Study for Relapsing-Remitting MS

*Clinical Trial Information from Veritas Medicine:*

*The CLARITY Study*

It’s about the freedom to choose the treatment that works best for
you. That’s why researchers are studying an oral form of an
investigational medicine (a tablet) to determine whether it is safe
and effective in treating relapsing-remitting multiple sclerosis.

The CLARITY Study is a double-blind clinical trial of an
investigational oral medicine (Cladribine) in the treatment of
relapsing-remitting multiple sclerosis. Certain forms of Cladribine
are approved for use in other illnesses, but research is still needed
on treating Multiple Sclerosis with Cladribine tablets.

*Find out now if you can take part*
Click here to answer a short series of questions to help determine
whether you can take part in this study. You are under no obligation
to participate, and all information you submit will be held in
confidence:

You will be under no obligation to participate and the information you
submit will be held in confidence.

Veritas Medicine
11 Cambridge Center
Cambridge, MA 02142

http://healthology.sparklist.com/t/94273/11728362/2724850/0/